Aspen Capital Management LLC Has $304,000 Holdings in Agilent Technologies, Inc. $A

Aspen Capital Management LLC grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 16.6% during the second quarter, Holdings Channel.com reports. The firm owned 2,573 shares of the medical research company’s stock after buying an additional 367 shares during the period. Aspen Capital Management LLC’s holdings in Agilent Technologies were worth $304,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Stone House Investment Management LLC acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $30,000. Ransom Advisory Ltd acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $32,000. Central Pacific Bank Trust Division acquired a new position in shares of Agilent Technologies in the 2nd quarter valued at about $33,000. Zions Bancorporation National Association UT acquired a new position in shares of Agilent Technologies in the 1st quarter valued at about $38,000. Finally, Costello Asset Management INC acquired a new position in Agilent Technologies in the first quarter worth approximately $47,000.

Agilent Technologies Stock Up 0.4%

A opened at $148.03 on Friday. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $41.97 billion, a price-to-earnings ratio of 34.75, a P/E/G ratio of 4.81 and a beta of 1.26. The business has a 50 day moving average of $130.39 and a 200-day moving average of $119.20.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.Agilent Technologies’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Analyst Upgrades and Downgrades

A has been the topic of a number of research reports. Barclays increased their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a report on Thursday, October 2nd. JPMorgan Chase & Co. increased their price objective on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a research report on Friday. UBS Group raised Agilent Technologies from a “neutral” rating to a “buy” rating and upped their target price for the stock from $130.00 to $170.00 in a research report on Wednesday, October 8th. Finally, Robert W. Baird upped their target price on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.